Legend Biotech | IPO Presentation Deck | 42 slides · page 24 of 42
The slide uses a comparative mechanism diagram to explain the problem of CAR-T relapse and the solution provided by LB1901.
Pitch deck · solution · present_solution · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 2/2 image 1/1 source-note 1/1 title 1/1
Components 5
primary primary illustration source-note headline
Tools 2
Before-After-Bridge slide · 60%
LB1901 would eliminate the potential contamination by Selection of Ab that will not prevent CAR+ tumor cells from CAR-T binding to the Ag on tumors;
Problem-Agitate-Solve (PAS) slide · 70%A new, rare mechanism of patient relapse is due to the presence of leukemic cells expressing CAR during manufacturing process.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.